NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.60 -0.07 (-0.48 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$14.60
Today's Range$14.31 - $14.70
52-Week Range$10.78 - $16.13
Volume1.84 million shs
Average Volume1.88 million shs
Market Capitalization$2.39 billion
P/E Ratio31.06
Dividend YieldN/A
Beta1.09
Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.41
Current Ratio0.94
Quick Ratio0.94

Price-To-Earnings

Trailing P/E Ratio31.06
Forward P/E Ratio26.07
P/E Growth1.79

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.41
Cash Flow$1.7958 per share
Price / Cash8.13
Book Value$6.42 per share
Price / Book2.27

Profitability

EPS (Most Recent Fiscal Year)$0.47
Net Income$-152,600,000.00
Net Margins0.10%
Return on Equity8.26%
Return on Assets2.24%

Miscellaneous

Employees8,900
Outstanding Shares174,610,000
Market Cap$2.39 billion

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions announced that its board has authorized a share repurchase program on Thursday, August 2nd 2018, which permits the company to buyback $250,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 11.3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) released its quarterly earnings results on Thursday, August, 2nd. The software maker reported $0.18 EPS for the quarter, meeting analysts' consensus estimates of $0.18. The software maker had revenue of $525.50 million for the quarter, compared to the consensus estimate of $536.93 million. Allscripts Healthcare Solutions had a return on equity of 8.26% and a net margin of 0.10%. The business's quarterly revenue was up 23.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.15 EPS. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share (EPS) guidance of $0.72 -0.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.15 -2.25 billion, compared to the consensus revenue estimate of $2.18 billion.

What price target have analysts set for MDRX?

15 Wall Street analysts have issued twelve-month target prices for Allscripts Healthcare Solutions' stock. Their predictions range from $14.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $16.5485 in the next year. This suggests a possible upside of 13.3% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 hold rating and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. According to Zacks Investment Research, "Allscripts ended the second quarter on a tepid note. The company continued to gain from the core software, delivery, support and maintenance unit. Growth in revenue cycle services and the acquisition of McKesson’s EIS business have presented it a competitive edge. The recently closed acquisition of HealthGrid is likely to expand the company’s FollowMyHealth patient engagement platform. Management is also optimistic about the gain from the sale of OneContent, which was closed earlier this year. Moreover, a solid guidance encourages. On the flip side, a year-over-year decline in bookings raised concern. In fact, management expects to see some volatility in bookings in the quarters ahead. Additionally, Allscripts saw a significant contraction in margins. The company is also exposed to integration risks. Intense competition in the niche space adds to the woes. Allscripts has underperformed the industry in a year’s time." (8/7/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on MDRX shares but lower our 12-month price target to $17 from $18. After the close, August 2, Allscripts reported 2Q18 results. Revenue was below our estimate but in line with FactSet consensus. Adjusted EPS was in line with our estimate. Bookings were disappointing, but the company held its 2018 guidance metrics. Notably, the company appears to be negotiating the sale of its stake in Netsmart, its behavioral IT unit. We had previously estimated that the company’s Netsmart stake was worth about $3 per share before any tax considerations." (8/2/2018)
  • 3. Maxim Group analysts commented, "1Q18 bookings of $304M, up 6.3% y/y, was below our estimate of $315M, but relatively inline with consensus of $305M." (5/4/2018)

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a drop in short interest during the month of July. As of July 31st, there was short interest totalling 13,060,818 shares, a drop of 13.2% from the July 13th total of 15,044,950 shares. Based on an average daily volume of 1,471,638 shares, the short-interest ratio is currently 8.9 days. Currently, 7.5% of the shares of the stock are sold short. View Allscripts Healthcare Solutions' Current Options Chain.

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 60)
  • Mr. Richard J. Poulton, Pres (Age 53)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

News articles about MDRX stock have trended somewhat positive on Saturday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a news and rumor sentiment score of 0.06 on Accern's scale. They also gave news headlines about the software maker an impact score of 47.51 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Allscripts Healthcare Solutions.

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (5.98%), Fuller & Thaler Asset Management Inc. (3.84%), Fisher Asset Management LLC (2.86%), Dalton Greiner Hartman Maher & Co. (1.78%), Fort Washington Investment Advisors Inc. OH (1.21%) and Paradigm Capital Management Inc. NY (1.16%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Michael Klayko, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Systematic Financial Management LP, Sei Investments Co., Federated Investors Inc. PA, Bank of Montreal Can, Cortina Asset Management LLC, Fisher Asset Management LLC and GAM Holding AG. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Fuller & Thaler Asset Management Inc., Renaissance Technologies LLC, Dimensional Fund Advisors LP, Fort Washington Investment Advisors Inc. OH, Community Trust & Investment Co., Victory Capital Management Inc. and Spark Investment Management LLC. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $14.60.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.39 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  518 (Vote Outperform)
Underperform Votes:  499 (Vote Underperform)
Total Votes:  1,017
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.